These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3990360)

  • 1. Effects of double filtration plasmapheresis on immunosuppressive activity of sera of the patients with advanced cancer.
    Miyazaki M; Sakagami K; Matsuoka J; Nishioka Y; Matsunaga T; Tsuboi K; Toda K; Matsumoto T; Tanaka K; Ohsaki T
    Life Support Syst; 1985; 3(1):92-4. PubMed ID: 3990360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. g. Plasmapheresis for patients with advanced cancer].
    Nakanishi K; Kameda A; Tomoda S; Toge T; Niimoto M; Hattori T
    Nihon Rinsho; 1984 Aug; 42(8):1886-92. PubMed ID: 6210379
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of cisplatin (CIS) during double filtration plasmapheresis (DFPP).
    Hosokawa S; Mizuno H; Abe R; Yoshida O
    Prog Clin Biol Res; 1990; 337():391-3. PubMed ID: 2191329
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on plasma exchange in advanced cancer patients with special reference to the postcentrifugal filter].
    Kameda A; Toge T; Yamada H; Aratani K; Kuroi K; Niimoto M; Hattori T
    Gan No Rinsho; 1985 Oct; 31(13):1661-4. PubMed ID: 4079056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis in the patients with malignant tumor].
    Kodama M; Tani T; Nakane Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1349-55. PubMed ID: 6378099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
    Seishima M; Shibuya Y; Kato G; Aoki T
    Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood purification therapy in cancer treatment.
    Tani T; Numa K; Hanasawa K; Kodama M
    Ther Apher; 1998 Aug; 2(3):182-4. PubMed ID: 10227767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels.
    Ebina T; Ogama N; Shimanuki H; Kubota T; Isono N
    Cancer Immunol Immunother; 2003 Sep; 52(9):555-60. PubMed ID: 14627127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of double-filtration plasmapheresis for the treatment of age-related macular degeneration.
    Yeh JH; Cheng CK; Chiu HC
    Ther Apher Dial; 2008 Dec; 12(6):500-4. PubMed ID: 19140849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neuronal antibodies in patients with cancer.
    Posner JB
    Ann Neurol; 2004 Nov; 56(5):609-10. PubMed ID: 15505822
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of selective albumin collection system by double filtration plasmapheresis.
    Mineshima M; Agishi T; Kaneko I; Era K; Ota K; Ide K; Fukui K
    Prog Clin Biol Res; 1990; 337():499-501. PubMed ID: 2353011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive factor in the sera of patients with stomach cancer--with special reference to IAP (immunosuppressive acidic protein)].
    Shimizu N; Izumi A; Ozaki Y; Kanayama H; Maeda M; Koga S
    Gan No Rinsho; 1982; 28(2):125-8. PubMed ID: 7182557
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants.
    Yeh JH; Lee MF; Chiu HC
    J Clin Apher; 2003; 18(1):32-6. PubMed ID: 12717791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria.
    Jiang X; Lu M; Ying Y; Feng J; Ye Y
    Ther Apher Dial; 2008 Dec; 12(6):505-8. PubMed ID: 19140850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of immunosuppressive acidic protein in gynecological cancer].
    Sato S; Wakisaka T; Hamazaki Y; Oikawa N; Toki T; Yamauchi R; Sakahira H; Tase T; Yajima A; Suzuki M
    Gan No Rinsho; 1983 Jul; 29(8):897-9. PubMed ID: 6887522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of a serum immunosuppressive (IS) substance in various diseases].
    Mannami T; Fuchimoto S; Amamiya S; Morioka S; Tanaka S; Tanaka N; Konaga E; Orita K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2104-12. PubMed ID: 6191693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.